Neuropace, Inc. - Common Stock — 분기별 재무 통계 (NASDAQ:NPCE) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

영업활동으로 인한 현금 -4.8 M-7.48 M-2.09 M-1.94 M506 K-5.9 M -9.42 M 투자 활동으로 인한 현금 1.96 M-37 K-168 K-30 K-97 K-117 K -412 K 재무활동으로 인한 현금 848 K21.11 M-1.91 M-235 K635 K-166 K -1.67 M 잉여 현금 흐름 -4.8 M-7.48 M-2.25 M-1.97 M409 K-6.02 M -9.84 M

뉴스

Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?

NPCE Explains How NeuroPace's RNS System Makes Money

NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care

NPCE Stock Gains on Q1 Earnings & Revenue Beat, 2026 Outlook Raised

NeuroPace, Inc. (NPCE) Q1 2026 Earnings Call Transcript

NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates

BSX Q1 Neuromodulation Sales Rise 15% Y/Y: What Lies Behind the Growth?

NeuroPace (NPCE) Moves 6.3% Higher: Will This Strength Last?

Key Catalysts That Will Likely Drive Prospects for NPCE Stock in 2026

NPCE RNS System Explained: Growth Drivers and Setup for 2026

NeuroPace's Seizure ID and New Indication Could Expand RNS Demand

뉴로페이스(NPCE) 최고 의료 책임자, 39만 9천 달러 상당의 주식 매도